Institutional Review Board
Institutional Review Board | |
---|---|
Term | Institutional Review Board |
Short definition | Institutional Review Board (IN-stih-TOO-shuh-nul reh-VYOO bord) A group of scientists, physicians, ministers, and patient advocates who review and approve the detailed plan for a clinical trial. Institutional review boards are designed to protect the people who participate in a clinical trial. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Institutional Review Board - (pronounced) (IN-stih-TOO-shuh-nul reh-VYOO bord) A group of scientists, physicians, ministers, and patient advocates who review and approve the detailed plan for a clinical trial. Institutional review boards are designed to protect the people who participate in a clinical trial. They check that the study is well designed, legal and ethical, does not involve unnecessary risks and includes a patient safety plan. Every healthcare facility that conducts clinical research has an Institutional Review Board, and each study is reviewed by an Institutional Review Board before the study begins. Also called IRB
External links
- Medical encyclopedia article on Institutional Review Board
- Wikipedia's article - Institutional Review Board
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski